[Federal Register Volume 59, Number 112 (Monday, June 13, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-14253]

[[Page Unknown]]

[Federal Register: June 13, 1994]


Centers for Disease Control and Prevention


Notice of Meeting

    The National Center for Environmental Health (NCEH) of the Centers 
for Disease Control and Prevention (CDC) will convene the following 
meeting sponsored by the Division of Environmental Health Laboratory 

    Name: Development of Innovative Technology for Measurement of 
Lead in Blood; Meeting of Grant Recipients and Cooperative Research 
and Development Agreement (CRADA) Partners.
    Time and Date: 6:30 p.m.-9 p.m., July 19, 1994.
    Place: New Orleans Marriott Hotel, 555 Canal Street, Mardi Gras 
Ballroom Sections F & G, New Orleans, Louisiana 70140.
    Status: Open to the public, limited only by space available.
    Purpose: The primary of this meeting is to brief the grantees 
and CRADA partners about CDC expectations for the grant and CRADA 
program, to encourage collaboration among grantees and CRADA 
partners and to review progress toward the objectives of the 
    Matters to be Discussed: Topics to be discussed include 
objectives of the CDC grant and CRADA program for the development of 
innovative technology for the measurement of lead in blood, impact 
of the Clinical Laboratory Improvement Act on the Technology, and an 
overview of each grantee and CRADA organization.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Robert L. Jones, Ph.D., 
Supervisory Research Chemist, Nutritional Biochemistry Branch, 
Division of Environmental Health Laboratory Sciences, (F18), NCEH, 
CDC, 4770 Buford Highway, NE, Atlanta, Georgia 30341-3724, telephone 
    Written comments are welcome and should be received by the 
contact person no later than July 13, 1994. Persons wishing to make 
oral comments at the meeting should notify the contact person in 
writing or by telephone no later than July 13, 1994. All requests to 
make oral comments should contain the name, address, telephone 
number, and organizational affiliation of the presenter. Depending 
on the time available and the number of requests to make oral 
comments, it may be necessary to limit the time of each presenter.

    Dated: June 2, 1994.
William H. Gimson,
Acting Associate Director for Policy Coordination, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 94-14253 Filed 6-10-94; 8:45 am]